Do lorazepam (Ativan) and alprazolam (Xanax) metabolize into the same compound that would be detected on a drug test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam and Alprazolam Do Not Metabolize Into the Same Compound for Drug Testing

No, lorazepam (Ativan) and alprazolam (Xanax) do not metabolize into the same compound that would be detected on a drug test. These benzodiazepines have different metabolic pathways and produce different metabolites that can be distinguished in drug testing.

Metabolic Pathways of Lorazepam and Alprazolam

  • Lorazepam undergoes direct glucuronide conjugation in the liver without producing active metabolites 1
  • Alprazolam, as a triazolobenzodiazepine, metabolizes primarily to alpha-hydroxy alprazolam and 4-hydroxy alprazolam, which are then further metabolized to glucuronide conjugates 2
  • The major urinary metabolites of alprazolam are alpha-OH alprazolam glucuronide and 3-HMB benzophenone glucuronide 2

Drug Testing Detection

  • Standard benzodiazepine immunoassay screening tests detect different metabolites for these medications 1:
    • Benzodiazepine panels often use a common metabolite (oxazepam) to identify an entire class of substances 1
    • However, individual benzodiazepines with variant metabolism can still be distinguished in confirmatory testing 1
  • Alprazolam and its metabolite alpha-OH alprazolam can be detected in urine drug screens at concentrations between 300-500 ng/mL 2
  • Lorazepam has a different metabolic profile and its glucuronide conjugates are detected separately 1

Confirmatory Testing Methods

  • Gas chromatography-mass spectrometry (GC/MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) can easily distinguish between lorazepam and alprazolam metabolites 2, 3
  • Confirmatory testing after a positive benzodiazepine screen can identify the specific benzodiazepine used 1
  • Approximately 20% of an alprazolam dose is excreted unchanged in the urine, while lorazepam is almost entirely converted to glucuronide conjugates 2, 1

Clinical Implications

  • False-negative results can occur with both medications if:
    • The timing of drug use relative to testing is outside the detection window 1
    • The cutoff concentration for a positive test is set too high 1
    • The specific metabolites are not included in the test panel 1
  • Benzodiazepine metabolism is affected by:
    • Hepatic dysfunction 1
    • Renal impairment 1
    • Age (clearance decreases with age) 1
    • Medications that inhibit cytochrome P450 enzyme systems 1

Common Pitfalls in Drug Testing

  • Some benzodiazepine screening tests may miss certain benzodiazepines or their metabolites 1
  • For example, benzodiazepine panels that identify oxazepam will not identify clonazepam, which has a different metabolic pathway 1
  • Interpreting drug test results is complex and should be done with caution, especially when results don't match clinical expectations 1
  • Seeking assistance from the testing laboratory is important when test results do not correlate with clinical findings 1

In summary, while both lorazepam and alprazolam are benzodiazepines, they have distinct metabolic pathways and produce different metabolites that can be distinguished in drug testing, particularly with confirmatory testing methods.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.